Science topic

Endothelial Function - Science topic

Explore the latest questions and answers in Endothelial Function, and find Endothelial Function experts.
Questions related to Endothelial Function
  • asked a question related to Endothelial Function
Question
3 answers
I'm planning to assess endothelial function in animal model of hyperglycemia .
Relevant answer
Answer
Hello
You can consider the following.
1. Thrombo modulin (TM) : It is a membrane protein expressed on the surface of endothelial cells. Soluble TM can be released from injured endothelial cells. It can be measured by ELISA.
2. von Willebrand factor : It is a glycoprotein released from endothelium upon endothelial cell injury. Increased levels are seen in plasma in vascular disease associated with diabetes. It can be estimated by ELISA.
3. E-selectin: It is expressed on the surface of cytokine-activated endothelial cells. Soluble E-selectin released from endothelial cells as a result of shedding of damaged cells. Estimation of this marker can be done by ELISA method.
I hope this is helpful.
Good Luck.
  • asked a question related to Endothelial Function
Question
7 answers
I detect the protein expression of enos(nos3) in huvec and cannot get results with enos.The expression of  other proteins are strong enough to detect .The only one cannot be detect is enos . 
I extracted the total protein of HUVEC. Also, the final concentration of total protein is about 5mg/ml. 
So ,I need anyone who detected enos in huvec by western blot to help me .
Thank you for your attention .
Relevant answer
Answer
Andy Wijaya Hi Andy, I´ve got fine results with HUVECs by using 10 µg protein/pocket, 10% SDS-Gel. I used eNOS antibody from CellSignaling (D8A6N) #35362 at 1:500 in 5% BSA, incubated overnight @ 4 °C. Secondary antibody was diluted 1:5000.
Good luck!
  • asked a question related to Endothelial Function
Question
8 answers
I am interested in studying all the physiological, neural, endocrine mechanisms associated with different breathing exercises suggested by traditional pranayama - such as ujjayi, bhramari, nadi suddhi, kapala bhaati, breath holding - and also other newer techniques. As part of this, I want to study how the endothelial functions change due to some of these practices. Hence, the question. I did not formally study biology or human physiology at any time. So, I have a lot of gaps in my knowledge w.r.t. human anatomy and physiology. I shall be grateful, if anyone can point me to good sources of information about the above, and also distinguished researchers who have contributed original knowledge in this field.
Relevant answer
Answer
The method I know is named vascular reactivity, so, I'm sending you the DOI of one of my group paper witch we work with endotelial function and a study material describing it (I'm sorry that the last one is in portuguese).
I hope I'm helpful.
  • asked a question related to Endothelial Function
Question
4 answers
Several standard buffer recipes have 11 mM glucose, and also sucrose. I realise buffers need osmolarity, but why such high sugar concentrations?
I used to use Holmans in myograph experiments, and at one point investigated the effects of high glucose on endothelial function. Couldn't help thinking my control preparations were already "hyperglycaemic".
Never had a satisfactory answer to this question.
Relevant answer
Answer
Hello
In the American Diabetes Association - 2020 ( https://doi.org/10.2337/dc20-S002 ) says that the diagnosis for diabetes can be given by fasting glucose (> = 126 mg / dL or 7 mM) or by 2 hours of glucose in plasma (> = 200 mg / dL or 11.1 mM) .
In other words, the Krebs solution (11 mM of glucose) would correspond to a glucose load test (ingestion of a glucose load containing the equivalent of 75 g of anhydrous glucose dissolved in water) measured 2 hours after the test.
We could say that the Krebs solution would be a post prandial Krebs
  • asked a question related to Endothelial Function
Question
3 answers
I am in the process of writing my systematic review in which I asses the longitudinal association between baseline endothelial function and diabetes type II at follow up in healthy participants. we selected only cohort studies. most of the studies didn't report the analysis between these two measures so we had to ask the authors for multivariate regression and they reported beta, standard error and significance. the analysis they did for endothelial function measure (FMD or RHI) and diabetes status measure (fasting plasma glucose or HbA1c) reported by 3 studies is insignificant as p value was insignificant. only one study reported baseline endothelial function and incidence of diabetes at follow up with significant relative ratio. and it matches with our hypothesis. now I have to conclude and discuss this two different outcome and build my case around it.
i want to ask that what things and factors I should consider in building my discussion. Any help in any direction would be very helpful. I feel like having two different outcomes is the key here but what could I use to differentiate between the two outcomes?
Thank you
Relevant answer
Answer
Monika Klimek-Tulwin thanks for your reply.
The insignificant p is for the 3 study with different follow up and population(smaller). however, one study with almost 840 participants showed the positive association but the type of outcome was different in this study. so it makes me think that we cannot completely invalidate the hypothesis. I am now thinking if it could be because of this difference in type of outcome(i.e diabetic measure Fasting plasma glucose, Hba1c & incidence of diabetes). for example, incidence of diabetes is due to many factors like environmental, family history etc.
  • asked a question related to Endothelial Function
Question
7 answers
I have longitudinal data with 2 follow ups at year 1 and 3. At baseline we have measure of endothelial function and we want to calculate the relation ship between endothelial function and diabetes type II. at follow up, the incidence of diabetes is recorded with self reported diagnosis or use of medication as the follow up was only done through interviews and questionnaire. we dont have the exact date of incidence of diabetes. which analysis method will be best to use for this type of data. survival analysis or mixed model? I understand for survival analysis I would need exact date of diagnosis of diabetes. but is there other assumptions that can make it possible to use it?
Relevant answer
Answer
The reflex here is to put in age as a covariate. The alternative, which makes better use of your age variable, is to use age as the time variable in a survival analysis. Participants enter at the age at which they were first surveyed and exit at the last survey age. This allows you to calculate the effect of your risk factor using a hazard function that starts at the earliest observed entry and ends at the last exit.
Ed Korn has a very good paper on this: Korn EL, Graubard BI, Midthune D. Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol. 1997 Jan 1;145(1):72–80.
  • asked a question related to Endothelial Function
Question
5 answers
I'm trying to get flow mediated dilation data to assess endothelial function using Reactive Hyperemia ( Occlusion).
What would be the best option to
a) get the data from one arm , take baseline measurement then occlude and get data during post reactive hyperemia.
b) consider one arm baseline measurement and use other arm for occlusion and get post reactive hyperemia data.
Relevant answer
Answer
Maybe the following papers will help you:
1. STORCH, Amanda Sampaio et al. Methods of Endothelial Function Assessment: Description and Applications. Int. J. Cardiovasc. Sci. [online]. 2017, vol.30, n.3 [cited 2018-04-27], pp.262-273.
2. Flammer AJ, Anderson T, Celermajer DS, et al. The Assessment of Endothelial Function – From Research into Clinical Practice. Circulation. 2012;126(6):753-767.
3. D Tousoulis, C Antoniades, and C Stefanadis.Evaluating endothelial function in humans: a guide to invasive and non-invasive techniques. Heart. 2005 Apr; 91(4): 553–558
  • asked a question related to Endothelial Function
Question
29 answers
It has been well documented that the TNF-alpha treatment of endothelial cells will significantly increase the expression levels of adhensive proteins, i.e. ICAM-1 and VCAM-1. Recently, I tried to used the TNF-alpha (Invitrogen) with different concentration (10, 100, 500 ng/mL) to treat the HUVECs for 48h. Then I did the immunostaining of ICAM-1 and VCAM-1, but I cannot see the expression differnece between treated HUVECs and untreated cells. I tried a couple of times and it did not work. Can anyone give some advice on this ? Thanks so much!
Relevant answer
Answer
Greetings Yonghui,
I worked with HUVEC throughout graduate school and regularly verifed enhanced expression of ICAM-1 or VCAM-1 in the presence of TNF (10ng/ml) after 16-20hrs exposure compared with untreated controls. Immunocytochemistry with a primary and secondary antibody was used. ICAM-1 showed a very large (4-20fold) higher signal which was obvious by eye under the microscope. VCAM-1 also showed an increased signal, but the effect was generally observed in a smaller percentage of the cell population, and the signal was lower in magnitude relative to ICAM-1. I hope this is useful for you. In addition, I am a bit surprised your cells are still alive after 48hrs treatment with 10ng/ml tnfa. In my experience the cells were often in bad shape if 20hrs exposure was exceeded. I had cultured the cells in M199 with 10%fbs and other supplements ( lglut, ecgs, pen strep). Since you are confident your TNFa stock is active, perhaps consider the staining method (are you getting backround signal in both groups, perhaps?). If you think the control/no treatment group is being inflamed as well, then I'd expect it to be a very large signal if it is equal to the tnfa treated group. If this is not the case then perhaps your tnfa-treated cells are dying/dead, or the surface ICAM-1 was primarily cleaved at that time point (48hrs). 
  • asked a question related to Endothelial Function
Question
6 answers
The view that shear is constant across the circulation appears to be dwindling, but is the view that shear increases in small arteries/microcirculation still controversial, or is there now a consensus?
Relevant answer
Answer
You have good reference articles (Cheng and Reneman). Physic at the microcirculation level has nothing to do with what is seen in big vessels (limit 250 micrometers). This is the border. None of the laws that applies over this limit applies under the limit. It's very tricky. With strange things and their consequences, for example the notion of additional drop pressure, depending on how much red cells flow in a small capillary and if they are separated or assembled...
  • asked a question related to Endothelial Function
Question
17 answers
Studies of NO-independent, hyperpolarization-mediated relaxation using myography often use the selective BKCa blocker iberiotoxin to delineate the role of transferable EDHFs, such as EETs or H2O2. More thorough studies demonstrate transferability through cascade or serial perfusion bioassays, but the majority of studies simply use iberiotoxin sensitive relaxation to "demonstrate" EDHF-type activity. The reality is that BKCa channels are activated prior to stimulation due to their intrinsic sensitivity to increased voltage, occurring following the induction of smooth muscle tone, thereby limiting the development of tone. Therefore, is it not just as likely that iberiotoxin sensitive relaxation is simply a reflection of BKCa no longer being able to limit tone? 
As I say, there ways to further substantiate the significance of an EDHF, but are those using just simple myography to arrive at that conclusion making an over-assumption?
Relevant answer
Answer
I think EDHF is a concept EDH is more accurate as it describes a set of processes  which evoke  endothelium dependent hyperpolarization and relaxation of smooth muscle. These include factors but also gap juntional communication. I Think most agree the term EDHF is redundant unless referring to a specific factor like an EET and then it is probably  better to just refer to that factor. Indeed by this definition  NO is also and EDHF and I think no one uses the term EDRF anymore and just refer to NO. IF you have relaxation you can't attitude to a  a single factor or is independent  of  a factor  then EDH  is probably  the correct term.
  • asked a question related to Endothelial Function
Question
4 answers
This may be an amateurish question, but it is a minor point outside my expertise that I want clarification. As an example, cytochrome P450 epoxygenases are often found in microsomes of vascular endothelial cells. Does this mean they are present in the ER of the intact endothelial cell?
Relevant answer
Answer
Hello. When you isolate microsomes, depending on the method, you may have several organelles. For example, it is easy to co-fractionate mitochondria and ER. You should always use bonafide organelle markers to learn the identity of your microsomes. Depending on the desired separation, whatever you get may be fine as long as you don't overstate your results. Hope this helps.
  • asked a question related to Endothelial Function
Question
3 answers
As I understand it, normal endothelial cells grow in-vivo on a basal lamina which notably includes collagen IV.
I recently read a paper which attempted to test JNK activation and atherosclerotic lesion formation in response to various basal laminae, including collagen and fibronectin. BAECs were used and were subjected to shear stress in a parallel-plate flow chamber.
However, what caught my eye was that they used collagen I instead of collagen IV in the course of their experiment. Hence, is there any reason in general for using collagen I instead of collagen IV in the course of the experiment?
Thanks for the answers. Of course I'm not expecting anyone to read the paper, but I'd just like to know if there was any reason that is not specific to this paper alone.
Relevant answer
Answer
The authors of the paper mentioned by the OP used Matrigel, type I collagen and fibronectin as substrates for BAEC culture.  Matrigel is a typical surrogate for basement membrane, while type I collagen and Fn are components of interstitial extracellular matrix, which the BAEC might be expected to see if the basement membrane was disrupted by inflammation or disease.  This kind of approach of varying the substrate matrix and monitoring cellular response is fairly typical, and has been used for some time, e.g. Madri, Pratt, & Yannariello-Brown. Amer. J. Pathol. 132:18, 1988.
  • asked a question related to Endothelial Function
Question
11 answers
Particularly interested in published data demonstrating this, if anyone knows of any.
Relevant answer
Answer
OK, found it now, the following is extracted from the methods section of :
ISOLATED PERFUSED RABBIT CORONARY ARTERY AND AORTIC STRIP PREPARATIONS: THE ROLE OF ENDOTHELIUM-DERIVED RELAXANT FACTOR
BY T. M. GRIFFITH, A. H. HENDERSON, D. HUGHES EDWARDS AND M. J. LEWIS, J. Physiol. 351, 13-24, 1984.
NOTE: the fixation step is not necessary for isolated arteries
Endothelial histology: Arterial preparations at the end of an experiment were stained by a modification of the method
of Poole, Sanders & Florey (1958). Perfused coronary artery preparations were perfused intraluminally with1% glutaraldehyde for 5min followed by1% silver nitrate for 2 min and then by a solution containing 3% cobalt bromide and 3% ammonium bromide for 2min. It was necessary to perfuse the arteries with glutaraldehyde before the silver nitrate in order to fix the tissue and prevent the severe constriction which the silver nitrate commonly caused and which itself caused further loss of endothelium. For the aortic strips the staining procedure was similar except that the glutaraldehyde step was omitted.
The endothelial surface of the arteries was visualized with a binocular microscope. An example of a coronary artery partially denuded of endothelium is shown in P1. 1. The entire surface of each preparation examined was scanned and a visual estimate made of the percentage of the surface stilcoveredbyendothelium.
Hope that helps.
  • asked a question related to Endothelial Function
Question
6 answers
hi anyone
I want to do cell culture in the inner surface of a tubular scaffold for vascular tissue engineering with the aim of regenerate a small diameter artery. but there is two limit case. first the time is short to cell death and second the adhesion of cell must be so strong for standing under shear stress.
now what is your suggest for me? with method is the best?
Relevant answer
Answer
Dear. Sneha Agarwal
thanks for your good advise.
  • asked a question related to Endothelial Function
Question
7 answers
What is the problem of the internal thoracic artery that feeds the mammary, when precontracted with NE and ANG II that leads to wobbling of the curve as you see in the attachment images.
Can anyone tell me what the problem is?
Relevant answer
Answer
We used to call this spontaneous activity and Dr Ward is absolutely right; it is really not a problem as long as you are able to quantify changes in vessel tone.
I remember on the other hand that mesenteric arteries (rat, rabbit, mouse, dog etc) actually show this type of 'behaviour' even at basal tone (i.e. without being pre-contracted with NE, Ang II or KCl).
Are these helicoidal strips and which physiological buffer are you using? In addition, if  you want to reduce these oscillations at least with an alpha agonist, try methoxamine instead and add indomethacin in your assay buffer. The addition of an inexpensive betablocker may also help.
Good luck
  • asked a question related to Endothelial Function
Question
3 answers
Cytokines involved in endothelial dysfunctions.
Relevant answer
Answer
most stimple is cytokine beads array using flow cytometry
  • asked a question related to Endothelial Function
Question
20 answers
See above
Relevant answer
Answer
I'm sorry if i didn't get you right, but what exactly is ethically unaccepted?
The best method depends on which patient collective you want to measure and to which extend you want to or can use provocation tests.
On of the classic tests would be the patients reaction regrading post-occlusive reactive hyperaemia. You can measure the response by device like the O2C by LEA or have a look at the Periflux devices. The choice also depends on your potential needs for further possibilities like trans-dermal drug application etc.
  • asked a question related to Endothelial Function
Question
8 answers
During organ bath, I am using aorta as a model, how I know that the function of endothelium detoriated beside using acetylcholine?
Relevant answer
Answer
You can also remove the endothelial layer mechanically with e.g. a hair by rubbing the lumen gently. Afterwards you can check the vasoconstrictor capacity with high concentration potassium (e.g. KPSS 60 mM) and the endothelium dependent relaxation with acetylcholine/carbachol after pre-constriction with e.g. 30 mM KPSS. Good luck
  • asked a question related to Endothelial Function
Question
10 answers
All methods to remove aortic endothelial cell and which one are the best?
Relevant answer
I use one of my own hairs!... I do it while the artery is mounted between wires with some tension on and gently rub in a circular motion with very gentle pressue against the artery wall/endothelium in one direction....this decreases Ach responses to less then 10%.
  • asked a question related to Endothelial Function
Question
7 answers
Diabetes has many complications, one of which is on reproduction (infertility). How can I mimic diabetes condition in a testes cell line? I have seen papers in which a pancreas (beta cell line) has been grown in high and low glucose to mimic diabetic conditions.
Relevant answer
Answer
Arun
A widespread approach is the use of hyperglycemia in vitro. Most groups use 5 mM glucose for control and 25 mM for hyperglycemia, mostly for 48 h or more. Please make sure to correct for the elevated osmolality by adding mannitose to the control culture. Good luck! JW
  • asked a question related to Endothelial Function
Question
8 answers
Our favourite kit is no longer available. We need advice about other kits and how they are working out for you, to find a new favourite.
Relevant answer
Answer
Thank you. I will check it out!
  • asked a question related to Endothelial Function
Question
40 answers
I have been infusing rats with angiotensin II, which causes severe vasoconstriction and probably should induce systemic hypoxia. How could I prove my hypothesis? I’m looking for a molecule or something that I could determine by ELISA. Does someone have experience with systemic hypoxia and HIF expression in the body?
Relevant answer
Answer
Hypoxia is a relative term. In a "normoxic" organism breathing air, many organs are "hypoxic". Moreover, ischemia implies local (not always systemic) hypoxia but the reverse is not rue. So, there is no established marker of hypoxia, but many markers of the response to hypoxia are available: most if not all of them have been listed above. So my suggestion would be to use the marker related to the "hypoxic" response you are investigating in your specific research. Good luck!
  • asked a question related to Endothelial Function
Question
3 answers
I have assessed endothelial function after acute exercise by peripheral arterial tonometry (endoPAT). The results for RHI declined after exercise, although the flow-mediated dilation assessed by ultrasonography increased.
Relevant answer
Answer
Dear Alex, many answers on your question you could find in Circulation (very useful journal for vascular research). Please note the influence of sympatic nerv.system in combination with NO in your case on endothelial function. I also could advise you to read science literature review from ITAMAR (endo PAT manufacture).
I have another question for you. How did you make fixation of ultrasound probe in your case? This detail could influence on final result of measurement.
Regards